220 related articles for article (PubMed ID: 34501688)
1. Oral Surgery Procedures in a Patient with Hajdu-Cheney Syndrome Treated with Denosumab-A Rare Case Report.
Kaczoruk-Wieremczuk M; Adamska P; Adamski ŁJ; Wychowański P; Jereczek-Fossa BA; Starzyńska A
Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501688
[TBL] [Abstract][Full Text] [Related]
2. Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab.
Adami G; Rossini M; Gatti D; Orsolini G; Idolazzi L; Viapiana O; Scarpa A; Canalis E
Bone; 2016 Nov; 92():150-156. PubMed ID: 27592446
[TBL] [Abstract][Full Text] [Related]
3. [Hajdu-Cheney Syndrome: a case of acroosteolysis].
Cunha I; Saavedra MJ; Oliveira MA; Salvador MJ; Malcata A
Acta Reumatol Port; 2007; 32(2):169-74. PubMed ID: 17576397
[TBL] [Abstract][Full Text] [Related]
4. First case of Hajdu-Cheney syndrome in Lithuania caused by novel NOTCH2 gene likely pathogenic variant.
Tėvelytė I; Bertašius P; Aleknavičienė K; Jonikas R; Klimaitė J; Jašinskienė E; Traberg R
Eur J Med Genet; 2024 Jun; 69():104938. PubMed ID: 38580081
[TBL] [Abstract][Full Text] [Related]
5. Acroosteolysis and facial dysmorphia: a new case of Hajdu-Cheney syndrome.
González Del Pozo P; Burger S; Pardo Campo E; Alperi López M; Queiro Silva R; Alonso Castro S
Reumatol Clin (Engl Ed); 2023 Nov; 19(9):527-529. PubMed ID: 37858457
[TBL] [Abstract][Full Text] [Related]
6. Letter to the Editor concerning "Hajdu Cheney syndrome; report of a novel NOTCH2 mutation and treatment with denosumab" by G. Adami et al. Bone 2016;92:150-156.
Jerzakowski G; Lasek T
Bone; 2017 Aug; 101():1-2. PubMed ID: 28411109
[No Abstract] [Full Text] [Related]
7. Hajdu-Cheney Syndrome: A Systematic Review of the Literature.
Cortés-Martín J; Díaz-Rodríguez L; Piqueras-Sola B; Rodríguez-Blanque R; Bermejo-Fernández A; Sánchez-García JC
Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32854429
[TBL] [Abstract][Full Text] [Related]
8. Effect of zoledronic acid on acro-osteolysis and osteoporosis in a patient with Hajdu-Cheney syndrome.
Hwang S; Shin DY; Moon SH; Lee EJ; Lim SK; Kim OH; Rhee Y
Yonsei Med J; 2011 May; 52(3):543-6. PubMed ID: 21488202
[TBL] [Abstract][Full Text] [Related]
9. Exploratory use of romosozumab for osteoporosis in a patient with Hajdu-Cheney syndrome: a case report.
Kim KJ; Hong N; Lee S; Shin S; Rhee Y
Osteoporos Int; 2023 May; 34(5):1005-1009. PubMed ID: 36622389
[TBL] [Abstract][Full Text] [Related]
10. Hajdu-Cheney syndrome: a case report with review of literature.
Palav S; Vernekar J; Pereira S; Desai A
J Radiol Case Rep; 2014 Sep; 8(9):1-8. PubMed ID: 25426244
[TBL] [Abstract][Full Text] [Related]
11. Capillaroscopic findings in a case of Hajdu-Cheney syndrome.
Damian LO; Simon SP; Filipescu I; Bocsa C; Botar-Jid C; Rednic S
Osteoporos Int; 2016 Mar; 27(3):1269-1273. PubMed ID: 26400009
[TBL] [Abstract][Full Text] [Related]
12. Hajdu-Cheney Syndrome, a Disease Associated with NOTCH2 Mutations.
Canalis E; Zanotti S
Curr Osteoporos Rep; 2016 Aug; 14(4):126-31. PubMed ID: 27241678
[TBL] [Abstract][Full Text] [Related]
13. High Bone Turnover in Mice Carrying a Pathogenic Notch2 Mutation Causing Hajdu-Cheney Syndrome.
Vollersen N; Hermans-Borgmeyer I; Cornils K; Fehse B; Rolvien T; Triviai I; Jeschke A; Oheim R; Amling M; Schinke T; Yorgan TA
J Bone Miner Res; 2018 Jan; 33(1):70-83. PubMed ID: 28856714
[TBL] [Abstract][Full Text] [Related]
14. Clinical and experimental aspects of notch receptor signaling: Hajdu-Cheney syndrome and related disorders.
Canalis E
Metabolism; 2018 Mar; 80():48-56. PubMed ID: 28941602
[TBL] [Abstract][Full Text] [Related]
15. Orofacial characteristics in a child with Hajdu-Cheney syndrome.
Saji S; Devi K P; Morankar R; Tewari N; Mathur VP; Bansal K
Spec Care Dentist; 2024; 44(2):428-433. PubMed ID: 37227705
[TBL] [Abstract][Full Text] [Related]
16. Hajdu-Cheney Syndrome: A Report on Successful Halting of Acro-osteolysis.
Duraiswamy G; Ashraf M; Sambandam SN; Shanmugasundaram S
JBJS Case Connect; 2021 May; 11(2):. PubMed ID: 34019492
[TBL] [Abstract][Full Text] [Related]
17. Two-year cyclic infusion of pamidronate improves bone mass density and eliminates risk of fractures in a girl with osteoporosis due to Hajdu-Cheney syndrome.
Galli-Tsinopoulou A; Kyrgios I; Giza S; Giannopoulou EZ; Maggana I; Laliotis N
Minerva Endocrinol; 2012 Sep; 37(3):283-9. PubMed ID: 22766895
[TBL] [Abstract][Full Text] [Related]
18. Nursing Care Plan for Patients with Hajdu-Cheney Syndrome.
Cortés-Martín J; Díaz-Rodríguez L; Piqueras-Sola B; Sánchez-García JC; Menor-Rodríguez MJ; Rodríguez-Blanque R
Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742738
[TBL] [Abstract][Full Text] [Related]
19. Off-label uses of denosumab in metabolic bone diseases.
Polyzos SA; Makras P; Tournis S; Anastasilakis AD
Bone; 2019 Dec; 129():115048. PubMed ID: 31454537
[TBL] [Abstract][Full Text] [Related]
20. Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab.
Matsumoto A; Sasaki M; Schmelzeisen R; Oyama Y; Mori Y; Voss PJ
Clin Oral Investig; 2017 Jan; 21(1):127-134. PubMed ID: 26924135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
